BRCA2 and breast cancer: Cancer genomic studies have revealed high-risk predisposing germline mutations, such as BRCA1/BRCA2, and other medium- to low-risk mutations in familial BC cases, including CHEK2, TP53, PTEN, and CDH1 [3,4].